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Intr
Renal biomarkers represent an attractive new diagnostic
tool which not only implies early diagnosis of AKI, but
provides also information about patients at risk for AKI
and prediction of adverse clinical outcome parameters
like the need for renal replacement therapy, length of
stay in ICU and mortality. Biomarker levels in urine how-
ever may be altered by intravascular volume availability
and chronic renal insufficiency.
Objectives
This study directly compared the diagnostic and prog-
nostic performance of biomarkers in urine and plasma.
Methods
This prospective cohort study included 110 unselected
adults undergoing cardiac surgery. Plasma and/or urine
concentrations of creatinine, cystatin C, neutrophil gelati-
nase-associated lipocalin (NGAL), liver fatty acid-binding
protein (L-FABP), kidney injury molecule 1 (KIM1), and
albumin and furthermore a multiplex panel of 15 biomar-
kers in plasma and urine were measured during the peri-
operative period. The primary outcome was AKI defined
by AKIN criteria.
Results
Biomarkers in plasma showed markedly better predictive
and diagnostic performance than their urinary counter-
parts. Discriminative power of urinary biomarkers
improved when concentrations were related to urinary
creatinine but still did not achieve AUC values of markers
measured in plasma samples. Before surgery plasma IP10
(interferon-g-induced protein 10, CXCL 10), cystatin C
and MIG (monokine induced by interferon-g, CXCL9)
best predicted postoperative AKI (AUC 0.73-0.70). Best
diagnostic performance 4h after surgery had NGAL (AUC
0.83), cystatin C (0.76), and MIG (0.74) in plasma. Combi-
nation with clinical scores (EuroSCORE and Cleveland
Clinic Foundation Score) or combinations of several bio-
markers did not significantly improve predictive or diag-
nostic power of either plasma or urine markers.
Conclusions
In our cohort plasma biomarkers had higher discrimina-
tive power to predict and to diagnose AKI than urine bio-
markers. Plasma IP10 and NGAL performed best in
predicting and diagnosing AKI respectively. Their perfor-
mance could not be improved by combining with clinical
scores or additional biomarkers.
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